Sign Up for a Free Account

Anastasia Zekeridou MD PhD

Department of Neurology and Laboratory Medicine and Pathology

Mayo Clinic

Rochester, Minnesota

Contributor Disclosures

Dr. Zekeridou of Mayo Clinic has a patent pending on the use of PDE10A-IgG as a biomarker of paraneoplastic autoimmunity.